CAS 96515-73-0: Palonidipine

Palonidipine is an antagonist of calcium, is potential for the therapy of angina-pectoris and hypertension.

Palonidipine is an experimental pharmaceutical compound classified as a calcium channel blocker, which is derived from synthetic chemical processes. This product functions by inhibiting the influx of calcium ions through L-type calcium channels located on the vascular smooth muscle cells and cardiac myocytes. By blocking these channels, Palonidipine causes vasodilation, reducing systemic vascular resistance, and thereby lowering blood pressure. The primary application of Palonidipine is in the potential treatment of hypertension, where it aims to offer an alternative mechanism for controlling elevated blood pressure levels. Additionally, its role in research extends to exploring its efficacy and safety profile in cardiovascular conditions involving calcium dysregulation. Ongoing studies are assessing its pharmacokinetics, pharmacodynamics, and long-term effects in preclinical and clinical settings. Further investigation is required to determine its clinical viability and possible advantages over existing medications in the same class.